The Indian American investor is winding down Shah Capital after reporting more than $1 billion in gains.
Browsing: Shah Capital
The vote is “truly a wake-up call for Novavax’s leadership” and “shareholders are clearly infuriated,” the activist investor says.
In a wide-ranging conversation on the podcast Inside Indian America, the Shah Capital founder reflects on markets, geopolitics, AI, and lessons from a three-decade career.
Shah Capital renews pressure on Novavax board, saying the biotech’s underperformance calls for a strategic sale to unlock value.
From Novavax to global equities, Raleigh, NC -based Shah Capital’s founder shares his investment philosophy and strategy